MedPath

Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of pulmonary tuberculosis in HIV patients; Egyptian experience

Phase 4
Conditions
Tuberculosis
Registration Number
PACTR202106822651688
Lead Sponsor
asem hewidy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
214
Inclusion Criteria

The study included seropositive HIV patients with a new diagnosis of either pulmonary or extra-pulmonary TB, and also included patients who were presented by symptoms suggestive for tuberculosis, changes in chest X ray that not improved by full course of antibiotics or positive tuberculin test = 5 mm.

Exclusion Criteria

Patients on anti-TB drugs or negative screening for sero-positive HIV patients were excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
tb diagnosis
Secondary Outcome Measures
NameTimeMethod
final diagnosis
© Copyright 2025. All Rights Reserved by MedPath